3Ferlay J,Shin H,Bray F,et al. Estimates of worldwide burden of cancer in 2008:GLOBOCAN 2008[J]. Int J Cancer,2010, 127(12) :2593-2917.
4Anaya-Ruiz M,Vallejo-Ruiz V,Flores-Mendoza L,et al. Female breast cancer incidence and mortality in Mexico,2000-2010 [J]. Asian Pac J Cancer Prey,2014,15(3):1477-1479.
5Pack G,Gallo J. The culpability for delay in the treatment of cancer[J]. Am J Cancer, 1938,33:443-462.
6Macleod U,Mitchell ED,Burgess C,et al. Risk factors for de- layed presentation and referral of symptomatic cancer:evidence for common cancers[J]. Br J Cancer,2009,101 (Suppl 2):S92- S101.
7Pedersen AF,Olesen F,Hansen RP,et al. Social support,gen- der and patient delay[Jl. Br J Cancer,2011,104(8) : 1249- 1255.
8Andersen R,Vedsted P,Olesen F,et al. Patient delay in can- cer studies:a discussion of methods and measures [Jl. BMC Health Serv Res,2009,9( 1 ) : 189.
9Walter F,Webster A,Scott S,et al. The Andersen Model of Total Patient Delay:a systematic review of its application in cancer diagnosis[Jl. J Health Serv Res Policy,2012,17(2): 110-118.
10Smith LK,Pope C,Botha JL. Patients' help-seeking experi- ences and delay in cancer presentation:a qualitative synthe- sis[J]. Lancet,2005,366(9488) :825-831.
